China Regenerative Medicine International Limited (HKG:8158)
0.3600
-0.0150 (-4.00%)
Feb 13, 2026, 4:08 PM HKT
HKG:8158 Market Cap
HKG:8158 has a market cap or net worth of 109.53 million as of February 13, 2026. Its market cap has increased by 18.03% in one year.
Market Cap
109.53M
Enterprise Value
178.30M
Revenue
58.22M
Ranking
n/a
PE Ratio
87.83
Stock Price
0.36
Market Cap Chart
Since July 18, 2001, HKG:8158's market cap has increased from 67.20M to 109.53M, an increase of 62.99%. That is a compound annual growth rate of 2.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 109.53M | -14.29% |
| Dec 31, 2025 | 127.79M | 42.37% |
| Dec 31, 2024 | 89.75M | -46.36% |
| Dec 29, 2023 | 167.34M | -47.18% |
| Dec 30, 2022 | 316.83M | -60.36% |
| Dec 31, 2021 | 799.20M | -50.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wuhan YZY Biopharma | 1.40B |
| Kintor Pharmaceutical | 1.38B |
| Beijing Biostar Pharmaceuticals | 1.35B |
| Shanghai Bio-heart Biological Technology | 1.31B |
| 3D Medicines | 1.13B |
| Brii Biosciences | 1.08B |
| Transcenta Holding | 1.06B |
| Sunho Biologics | 970.43M |